Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Fenwal Named Exclusive Provider of AccuVein's Award-Winning Vein Illumination Device for Blood and Plasma Centers

October 18, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

LAKE ZURICH, Ill., Oct. 18 /- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a three-year, exclusive agreement with AccuVein LLC to sell, market and distribute the AccuVein AV300...

A new order for CPR, spelled C-A-B

October 18, 2010 6:31 am | by EurekAlert | News | Comments

(American Heart Association) The 2010 AHA Guidelines for CPR and ECC update the 2005 guidelines. When administering CPR, immediate chest compressions should be done first. Untrained lay people are urged to administer hands-only CPR (chest compressions only).

Federal Register: Medical Device User Fees; Public Meeting; Extension of Comment Period

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is extending to November 1, 2010, the comment period for the notice that appeared in the Federal Register of August 13, 2010 (75 FR 49502).

Advertisement

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices a...

October 18, 2010 5:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Cellectis In-Licenses Induced Pluripotent Stem Cell Technology From iPS Academia Japan

October 18, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

PARIS and KYOTO, Japan, Oct. 18 /- Cellectis (Alternext: ALCLS), the French genome engineering specialist, and iPS Academia Japan Inc. (Kyoto, Japan) announced today that they have signed two separate non-exclusive agreements granting Cellectis worldwide access to the induced Pluripotent...

S.D. Firms Discuss Future of Wireless Health in D.C.

October 17, 2010 11:31 pm | by San Diego Business Journal | News | Comments

With the digital dialogue between patient and provider promising brave new worlds and opportunities in health care and commerce, face-to-face meetings drew representatives from several San Diego startup medical device companies and a medical research organization advocating for wireless...

Study documents wrong-site, wrong-patient procedure errors

October 17, 2010 10:30 pm | by EurekAlert | News | Comments

(JAMA and Archives Journals) Data from one liability insurance database in Colorado indicate that wrong-site and wrong-patient surgical and procedure errors continued to occur despite nationwide steps to help prevent them, according to a report in the October issue of Archives of Surgery,...

Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum

October 17, 2010 8:33 pm | by Bio-Medicine.Org | News | Comments

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the...

Advertisement

Experimental Drug Preserves Memory in Rodents

October 17, 2010 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A new compound prevents age-related memory loss by blocking part of the stress system.

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood

October 17, 2010 7:32 pm | by Bio-Medicine.Org | News | Comments

Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood -- SINGAPORE, Oct. 17 /PRNewswire-Asia/ --

Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010

October 17, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

SAN CARLOS, Calif., Oct. 17 /- Nektar Therapeutics (Nasdaq: NKTR ) today presented new preclinical data demonstrating that NKTR-181, a mu-opioid analgesic with a novel molecular structure, dramatically reduces abuse liability while providing analgesia comparable to oxycodone and morphine....

Blood pressure, glaucoma links in migraine patients; eye care goes digital and mobile

October 17, 2010 6:31 am | by EurekAlert | News | Comments

(American Academy of Ophthalmology) Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today's scientific program, to be presented at the 2010 American Academy of Ophthalmology -- Middle East-Africa Council of Ophthalmology...

Galenea wins $4.5M NIH grant

October 17, 2010 4:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge biopharmaceutical firm Galenea Corp. has won a $4.5 million grant from the National Institute of Mental Health for a technology platform aimed at identifying compounds to treat schizophrenia.

Advertisement

Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date

October 17, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

WORCESTER, Mass., Oct. 15 /- Generex Biotechnology Corporation (Nasdaq: GNBT, www.generex.com ) today announced that it reconvened a special meeting of stockholders (the "Special Meeting") on October 15, 2010 at 10:00 a.m. (local time) at the Meeting Rooms, Westin Harbour Castle Hotel, 1...

New Online Pharmacy RxBuys.com is Launched by One of the Leading Pharmaceutical Companies, Rx Corp

October 17, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

MEMPHIS, Tenn., Oct. 17 /- The new online pharmacy was launched after the company had studied the market of pharmaceuticals, coming to the conclusion there are not enough reliable and trustworthy places to shop for high quality prescription medications. With the many years of experience...

Long-Term Data Show Novartis Once-Yearly Reclast Preserves Bone Mass and Provides Fracture Protection in Postmenopausal Osteoporosis

October 16, 2010 4:31 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Oct. 16 /- Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.(1) The study of more than 1,200 women was presented this...

ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™

October 16, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Oct. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye...

Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches ...

October 16, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- AdvaMed 2010 : The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global...

Acute Cardiac Care 2010

October 16, 2010 12:31 am | by EurekAlert | News | Comments

(European Society of Cardiology) Today in most countries of the world almost 50 percent of patients in hospital for a cardiac condition began their treatment as emergency cases: chest pain at home or cardiac arrest in the street.

Excelsior Medical 5 ml Fill in 6 cc Prefilled Saline Flush Syringes: Recall - Potential Loss of Sterility

October 15, 2010 12:31 pm | by U.S. Food & Drug Administration | News | Comments

Exposure to syringes with a sterility issue could result in systemic infection, which may lead to serious injury and/or death.

CareFusion Corporation Alaris PC Units (Model 8015): Recall - Potential for Delay or Interruption of Therapy

October 15, 2010 11:30 am | by U.S. Food & Drug Administration | News | Comments

Hardware communication error may lead to serious injury or death.

Methodist Mansfield Medical Center Donates 4,000 Pedometers for Entire Mansfield ISD Staff

October 15, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

MANSFIELD, Texas, Oct. 15 /- Methodist Mansfield Medical Center will provide a pedometer to every staff member of the Mansfield Independent School District as well as sponsor a Principals' Fitness Challenge program to promote the importance of health and fitness. By helping principals and...

Isis Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

October 15, 2010 10:31 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Oct. 15 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010 at 11:00 a.m. ET at...

CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall

October 15, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 15 /- CareFusion (NYSE: CFN ), a leading, global medical device company, issued the following update regarding its previously disclosed recall of approximately 17,000 Alaris® PC units model 8015 manufactured or serviced between December 2008 and September 2009. The...

Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference

October 15, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., Oct. 15 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the 17th Annual NewsMakers in the Biotech Industry Conference on Friday, October 22, 2010.  The presentation is scheduled for 9:00 a.m. Eastern Time.  The session may be...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading